RTC
CVS icon

Riverview Trust Company’s CVS Health CVS Stock Holding History

Riverview Trust Company’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.54K Sell
105
-313
-75% -$24.1K 0.01% 174
2025
Q4 		$33.2K Hold
418
– – 0.04% 139
2025
Q3 		$31.5K Hold
418
– – 0.04% 142
2025
Q2 		$28.8K Sell
418
-538
-56% -$35.3K 0.04% 153
2025
Q1 		$64.8K Buy
956
+520
+119% +$31.1K 0.06% 193
2024
Q4 		$19.6K Sell
436
-421
-49% -$23.6K 0.02% 477
2024
Q3 		$53.9K Sell
857
-349
-29% -$20.4K 0.05% 227
2024
Q2 		$71.2K Sell
1,206
-8,466
-88% -$530K 0.07% 183
2024
Q1 		$771K Buy
9,672
+91
+0.9% +$6.95K 0.59% 35
2023
Q4 		$757K Hold
9,581
– – 0.77% 33
2023
Q3 		$669K Buy
9,581
+150
+2% +$10.6K 0.59% 35
2023
Q2 		$652K Buy
9,431
+292
+3% +$20.8K 0.59% 35
2023
Q1 		$679K Sell
9,139
-1,593
-15% -$134K 0.62% 35
2022
Q4 		$1M Sell
10,732
-453
-4% -$43.7K 0.95% 23
2022
Q3 		$1.07M Buy
11,185
+136
+1% +$13.5K 1.03% 17
2022
Q2 		$1.02M Sell
11,049
-224
-2% -$21.9K 0.89% 23
2022
Q1 		$1.14M Buy
11,273
+863
+8% +$90.7K 0.85% 22
2021
Q4 		$1.07K Hold
10,410
– – 0.63% 21
2021
Q3 		$883K Hold
10,410
– – 0.93% 23
2021
Q2 		$869K Hold
10,410
– – 0.92% 24
2021
Q1 		$783K Hold
10,410
– – 0.87% 27
2020
Q4 		$711K Buy
10,410
+1,617
+18% +$105K 0.79% 27
2020
Q3 		$514K Hold
8,793
– – 0.59% 35
2020
Q2 		$571K Hold
8,793
– – 0.55% 36
2020
Q1 		$522K Hold
8,793
– – 0.5% 32
2019
Q4 		$653K Sell
8,793
-1,262
-13% -$88.6K 0.44% 44
2019
Q3 		$634K Hold
10,055
– – 0.44% 43
2019
Q2 		$548K Sell
10,055
-185
-2% -$9.96K 0.39% 50
2019
Q1 		$552K Sell
10,240
-70
-0.7% -$4.32K 0.42% 47
2018
Q4 		$676K Buy
+10,310
New +$770K 0.53% 32

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Riverview Trust Company's CVS Position: Q1 2026 in Review

Riverview Trust Company reduced its CVS Health (CVS) stake by 75% in Q1 2026, selling an estimated $24.1K and leaving 105 shares worth $7.54K. The position accounts for 0.01% of the portfolio, ranked #174.

Riverview Trust Company first reported a position in CVS in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.14M in Q1 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Riverview Trust Company held 105 shares of CVS Health worth $7.54K as of Q1 2026.
  • Riverview Trust Company sold 313 CVS Health shares in Q1 2026, an estimated $24.1K.
  • CVS Health made up 0.01% of Riverview Trust Company's portfolio in Q1 2026, its #174 holding.
  • Riverview Trust Company first reported a position in CVS Health in Q4 2018 and has held it in 30 quarters since.
  • Riverview Trust Company's CVS Health position peaked at $1.14M in Q1 2022.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Riverview Trust Company's 13F filing for Q1 2026, filed 1 May 2026.